Diagnosis and treatment of Alzheimer´s and other neurodementing dseases
A-beta-autoantibodies were isolated from the serum of Alzheimer patients. The cDNA and amino acid sequences of the variable regions of the heavy and the light chains were determined and all possible pairings of the chains were expressed in mammalian cells.<br>
A number of these pairings were found to bind with higher affinity to A-beta dimers than to A-beta monomers. One of these was shown to possess biological activities potentially useful for the treatment of Alzheimer´s disease.<br> Consensus sequences were determined and used to prepare human anti-beta-amyloid antibodies useful for preventing or treating neurodementing diseases like Alzheimer´s. These human anti-beta-amyloid antibodies are suitable for detecting and measuring the progression of neurodementing disease and methods are provided for delaying the onset or progression of these diseases.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Future AR/VR controllers could be the palm of your hand
Carnegie Mellon University’s EgoTouch creates simple interfaces for virtual and augmented reality. The new generation of augmented and virtual reality controllers may not just fit in the palm of your…
‘Game changer’ in lithium extraction
Rice researchers develop novel electrochemical reactor. A team of Rice University researchers led by Lisa Biswal and Haotian Wang has developed an innovative electrochemical reactor to extract lithium from natural…
The blue-green sustainable proteins of seaweed
… may soon be on your plate. The protein in sea lettuce, a type of seaweed, is a promising complement to both meat and other current alternative protein sources. Seaweed…